William (Bill) Guyer in

William (Bill) Guyer

Login to view DISC.
Chief Development Officer (CDO) at Corcept Therapeutics
📍 Redwood City, California, United States

William (Bill) Guyer is the Chief Development Officer at Corcept Therapeutics, bringing 30 years of transformational leadership in the pharmaceutical industry. His expertise lies in advancing therapeutics from development to commercialization across areas like oncology and infectious diseases, previously serving as a Senior Vice President at Gilead Sciences. He holds a PharmD from the University of Southern California.

Outside of his executive roles, Bill demonstrates a strong commitment to patient welfare and community support. He has led initiatives to help elderly patients in need and consistently emphasizes a patient-centric approach in his professional endeavors, focusing on therapies for those with critical unmet medical needs.

Unique fact: Bill is a Registered Pharmacist in both California and Nevada.

Read the full overview →
Experience
35 Years
Current Role
Chief Development Officer (CDO)
Job Level
Leadership
Location
Redwood City, California, United States
Personality Overview

How William shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics William cares about

Drug Development
His career spans 30 years leading the development and global launch of new therapeutics, from Phase 1 through commercialization, at companies like Gilead and Corcept.
Oncology Pipeline
He is actively building out Corcept's oncology program, seeking strategic leadership to advance the company's pipeline in this therapeutic area.
+5 more topics Login to view topics
Career

Work history

8-2021
Chief Development Officer (CDO)
Corcept Therapeutics
3-2015 - 8-2021
Senior Vice President
Gilead Sciences
2-2013 - 3-2015
Vice President, AntiVirals (HIV, HCV, HBV)
Gilead Sciences
2-2012 - 2-2013
HCV Global Senior Medical Director
Gilead Sciences
2-2009 - 2-2012
HIV Global Senior Medical Director
Gilead Sciences
In the press

Media appearances

Corcept therapeutics exec Guyer sells $1.79 m in shares. Featured in Investing.com
See now
Education
PharmD
University of Southern California
6-2019 - 6-2019
Director Development Program
Stanford University Graduate School of Business
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

Other Corcept Therapeutics Employees

Explore more public profiles from related professionals.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to William. Free, 10 seconds.